Source: Eur Respir J, 50 (6) 1701344; 10.1183/13993003.01344-2017
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Jayne C. Carberry, Lauren P. Fisher, Ronald R. Grunstein, Simon C. Gandevia, David K. McKenzie, Jane E. Butler, Danny J. Eckert. Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem. Eur Respir J, 50 (6) 1701344; 10.1183/13993003.01344-2017

Member's Comments

No comment yet.

Related content which might interest you: The puzzle of metabolic effects of obstructive sleep apnoea in children Source: Eur Respir J 2016; 47: 1050-1053 Year: 2016 The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Should caffeine be avoided in obstructive sleep apnea? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Changes in baroreflex activity in obstructive sleep apnea: cause or consequence? Source: Eur Respir J 2007; 30: Suppl. 51, 748s Year: 2007 The effect of adenotonsillectomy on frequent positional change during sleep in pediatric obstructive sleep apnea syndrome Source: Annual Congress 2008 - Alternatives for continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2008 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 The metabolic consequences of obstructive sleep apnoea in children Source: Breathe 2009; 6: 111-114 Year: 2009 The familial occurrence of obstructive sleep apnoea symptoms Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003 Influence of electrostimulation of pharyngeal and laryngeal muscles with application of prolonged beta-2 agonist on functional signs of obstructive sleep apnea syndrome in patients with obstructive sleep apnea syndrome combined with chronic obstructive Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003 The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016 Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment Source: Eur Respir J 2013; 41: 593-600 Year: 2013 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 Obstructive sleep apnoea: the effect of intermittent hypoxia on cognitive function Source: ERS Conference Year: 2015 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Sex differences in obstructive sleep apnoea Source: Eur Respir Rev, 28 (154) 190030; 10.1183/16000617.0030-2019 Year: 2019 Nicotine dependence in tunisian patients with severe obstructive sleep apnea (OSA) Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Cardiovascular comorbidity by clinical phenotypes of obstructive sleep apnea and sleeping hours Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020